Commandité
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posté
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Rechercher
Catégories
- National
- International
- Business
- Technology
- Health
- Éducation
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Lire la suite
Raj's ex-wife drops cryptic note amidst buzz about Samantha
Samantha Ruth Prabhu and filmmaker Raj Nidimoru are making headlines for their rumoured...
Nepal, Bhutan discuss joint efforts on climate change and himalayan issues
KATHMANDU: Minister for Forests and Environment, Ain Bahadur Shahi Thakuri, met with...
© 2025 Dununu.com : Circle of Life - Santan Social Network
French
